BAM15: The Definitive Guide

What is BAM15?

BAM15 is a lab-made chemical that makes mitochondria, the energy-producing parts of cells, burn fuel less efficiently, so more of the energy escapes as heat. It is sold online as capsules for fat loss, but it has only been studied in cells and animals, and no human dose has been established. [1], [2], [3]

It is a small molecule, a single compact chemical (formula C16H10F2N6O, 340.29 g/mol), not a peptide (a chain of amino acids), even though peptide shops usually sell it. The name is a laboratory code, also written BAM-15 or BAM 15. Researchers at the University of Virginia described it in 2014 after screening chemicals for a mitochondrial uncoupler that would leave the cell's outer plasma membrane alone. [4], [1]

The best-known older uncoupler is DNP, an early weight-loss drug with a narrow gap between an effective and a toxic amount, which the FDA banned for human use in 1938. The hope behind BAM15 is a similar fat-burning effect with a wider margin of safety. That hope has never been tested in a person. [2]

The key word is investigational. No published study has given BAM15 to people, and no human trial is registered. We found no approval for it in the United States, Canada or Australia, and it is banned in sport. [3], [5], [6], [7], [8]

Typical BAM15 Protocols

Read the units: website figures are usually in milligrams (mg), while a few pages and blend labels use micrograms, and 1 mg equals 1,000 mcg. Capsule labels give the strength of one capsule, not a daily total. Animal figures are different again: a share of the food by weight, or an amount per kilogram of body weight. None of these can be swapped for another. [2], [17], [25]

These figures come from animal experiments and from websites, not from any study in people, and the cited references give the full details. Because no human dose exists, this guide does not convert any amount into syringe units and does not link a mixing calculator. [3], [2]

What about blends with SLU-PP-332?

BAM15 is often sold premixed with SLU-PP-332, another investigational compound promoted as an "exercise mimic". The blends are the main reason people misread the amount they are taking, because the product name and its total weight say nothing about how much BAM15 is inside. [28], [29]

Blend labels do not even agree on the scale. Sellers of nominally similar capsules state the BAM15 content as 50 micrograms on one product and 50 milligrams on another, a thousand-fold difference, and one public account describes capsules labelled in micrograms while forum discussion of the same kind of product is in milligrams. A third product, now retired, stated a much smaller amount again, and one retail page gives no BAM15 amount at all. [30], [31], [32], [29], [33]

Neither compound has been tested in people, alone or together, so a blend is two unstudied compounds in one capsule. The Doserly guide to the SLU-PP-332 and BAM15 blend covers these products in more detail. [3], [34]

Where the sources disagree, and why the numbers are so far apart ↓

What is BAM15 commonly used for?

Most people look into BAM15 for stubborn body fat or a weight-loss plateau, often while already taking a GLP-1 medicine such as semaglutide or tirzepatide, or the investigational drug retatrutide. A smaller group is interested in energy, endurance, blood sugar or aging muscle. The appeal is a different route to fat loss: GLP-1 medicines mainly reduce appetite, while BAM15 is promoted as making the body waste more energy as heat. That idea comes from mouse and cell studies. No study has tested whether BAM15 helps a person lose fat, feel more energetic or become healthier, and the most detailed public reports describe modest or absent results. [35], [36], [37], [2], [9], [3], [38]

Fat loss and weight-loss plateaus

This is the main use. In the key mouse studies, BAM15 was mixed into the food of mice made obese on a high-fat diet. The mice ate the same as untreated mice but burned more energy, and they gained less fat or lost fat they already had: in one study, mice fattened for four weeks and then fed BAM15 for five weeks ended up 15% lighter, almost all of the difference being fat. The result depends on the model, though. In mice with a severe genetic form of obesity and diabetes, the usual food level did not change body weight and only a doubled level did, and in a mouse model of fatty liver disease BAM15 alone made no significant difference to weight, fat or muscle at all. [2], [9], [39], [13]

People usually add BAM15 when weight loss has stalled on something else. That makes any result hard to read, because the other medicine, diet changes and training are all still working. [36], [35], [40]

"Fat loss without the heat": the DNP comparison

Much of the interest comes from the comparison with DNP. In the 1930s, doctors prescribed DNP for weight loss, and patients lost weight quickly without eating less, but the gap between an effective and a toxic amount was narrow. DNP is still sold illegally, and the FDA warns that it can cause dangerously high body temperature, cardiac arrest and death. In mice, BAM15 behaved differently: single amounts far above those used in the fat-loss studies did not change body temperature, while the highest DNP amount without observed harm in the same tests was much lower. That finding is the source of the "safer DNP" label. It has never been checked in a person, and the risks section explains why a mouse result is not enough. [2], [11] A 2026 qualitative study of discussion on two of the largest bodybuilding forums, and of a YouTube video showing how to make BAM15, found that some users saw it as a promising, low-risk alternative to DNP, and many commenters said they intended to try it despite limited clinical evidence. [112]

Energy, endurance and exercise

People describe energy and workout endurance more often than measured fat loss, sometimes alongside warmth and heavy sweating. These are impressions without measurements, usually while taking other compounds, and several people report feeling tired rather than energetic. [38], [41], [35], [42]

Blood sugar and fatty liver

In several mouse models, BAM15 improved how well the animals handled sugar and reduced fat in the liver. In one head-to-head study in diabetic mice, it lowered body weight and liver fat more than a mouse dose of semaglutide, while several of the drugs improved blood-sugar control. These are mouse findings in a genetic diabetes model. They do not show that BAM15 works better than an approved medicine in people. [2], [39], [43]

Muscle and aging

In 80-week-old obese mice, old for a mouse, those given BAM15 in food for ten weeks weighed about 42 g on average, against 54 g for untreated mice, and a larger share of their weight was muscle, with a stronger grip. A 2025 preprint, which has not been through peer review, reports better muscle force in both sexes of 24-month-old mice, with mitochondrial improvements only in the males. Studies in worms and fruit flies found longer lifespans. None of this has been tested in older people. [12], [44], [45], [46]

Other research uses

Scientists also use BAM15 as a laboratory tool and have tested it in mouse models of sepsis, kidney injury, hardened arteries, lung injury and several cancers. In one sepsis study, 75% of treated mice were alive after a week compared with 25% of untreated mice. These are disease models in animals, not evidence for consumer use. [14], [1], [47], [48], [49]

See why there is no human evidence or explore the supporting mouse and cell research.

Where do BAM15 protocols differ?

Because no study has ever set a human amount, every figure online was built from something else: an animal experiment, a capsule label, an arithmetic conversion or a forum post. Knowing which one tells you how much weight to give it, and the honest answer is that none of them has been tested.

Why do the figures disagree by more than a hundred thousand times?

Each page picks its own starting point. One forum guide is written in micrograms, a harm-reduction page starts at 5 mg, most pages sit in the tens, protocol pages run into the low hundreds, one capsule label works out at several hundred milligrams a day, and one public self-experiment log records more than a gram a day. From the smallest to the largest, that is a spread of more than 100,000 times for the same compound. [17], [18], [19], [23], [25], [50]

No page cites a human dose-finding study, because none exists. Two also get the key mouse paper wrong: one credits it to the wrong author, and another gives the wrong DOI, the paper's permanent identifier. [24], [27]

Is the number per capsule, per dose or per day?

Often it is impossible to tell, and the difference is large. One protocol page lists a tier in a column headed "Dose" beside a column saying twice daily, which read literally is double the daily figure the same page states in its conclusion. Capsule labels give the strength of one capsule, so a page that also suggests several capsules is describing a much larger daily total than its headline number. Check which of the three a figure is before comparing it with anything else. [23], [25]

Why do some pages split the day and others not?

Pages that split the day point to a short half-life of about 1.7 hours. That figure was measured in mice given a single amount by stomach tube; in mice eating BAM15 in their food it was about 3 hours, and in people it has never been measured at all. A half-life from another species is not a schedule. [24], [23], [2], [9]

Sources disagree about food too, some saying with meals and others before breakfast, and one person reported diarrhea whenever they took it without food. No study has compared the two in any species. [19], [21], [51]

Do sources agree on how long a course should be?

No. Most describe courses of a few weeks to a couple of months, with breaks that range from a fortnight to an equal period off, and one page says plainly that its own on-and-off pattern is a convention rather than a tested schedule. The honest reason for any limit is that nobody has been observed taking BAM15 for longer, not that a break is known to prevent anything. [52], [23], [25]

Where do the biggest numbers come from?

From arithmetic. Some pages convert the amount obese mice ate into a figure for a 70 kg person, and one labels its own calculation as illustrative rather than a regimen. That arithmetic has two problems. Mouse food levels, stomach-tube amounts and injections are different exposures that cannot be merged into one number. And the regulator's conversion method is only a step toward a cautious first amount in a supervised trial, after which a safety factor is applied; it was never meant to produce a number for use at home, and no such trial has been run. [26], [27], [9], [53]

Are single pages even consistent with themselves?

Not always. One page carries a wide daily range, a separate table of much larger daily figures and a smaller starting schedule, all for the same compound. A dosing template lists an injection while calling BAM15 an oral drug elsewhere on the page, and a retail page describes its capsules as containing an enzyme rather than BAM15, which suggests the text was copied from a different product. Check the units, the per-dose or per-day label and the ingredient name on every figure you read. [24], [54], [55]

What happens when you stop BAM15?

Nobody has studied it. No published experiment followed animals after BAM15 was withdrawn, and no person has been followed in a study at all, so there is no evidence about weight regain, rebound effects or withdrawal symptoms. [3], [2]

Two things can be said honestly. In mice the level in the blood fell by half within a few hours, so the compound itself clears quickly, although whether any effect clears with it is unknown. And in public reports, people who stopped describe effects fading: one person's unusual body odor disappeared when they stopped and returned when they restarted, and another paused because of tiredness. Those are individual accounts, not a study of stopping. The pattern of stopping after a few weeks that dosing pages describe is not based on what happens when people stop, but on nobody knowing what happens if they continue. [2], [9], [36], [35], [52]

Does BAM15 work as a pill, and how long does it last?

In mice, yes. When mice were given BAM15 by mouth and into a vein, 67% of the swallowed amount reached the blood. That share is called bioavailability, and it has never been measured in a person. The mouse result contradicts a claim repeated online, that BAM15 "is not orally available"; the reasoning behind that claim, that stomach enzymes destroy peptides, does not apply to a small molecule. [2], [37], [4]

How long does it last in the body?

Half-life is the time it takes for the level in the blood to fall by half. It is not how long an effect lasts.

The two mouse studies also disagree about where it goes: in one it went mainly to the liver, with tissue levels falling over about four hours, and in the other most of it sat in fat tissue, then the liver, heart and kidneys. There are no human pharmacokinetic data of any kind. A 2026 laboratory study incubated BAM15 with human liver enzymes and tentatively identified 13 breakdown products, but a test tube cannot show how quickly a person clears a drug. [2], [9], [56]

Why is it hard to work with?

BAM15 barely dissolves in water. The original researchers mixed it into food for their long studies partly for that reason, and when they tried single amounts by stomach tube they had to stop escalating because it would no longer dissolve. One dosing site notes the same problem with homemade capsules: the powder may not spread evenly, so two capsules from one batch need not hold the same amount. [2], [24]

What about injections, skin products and patches?

Almost everything sold for people is swallowed. One dosing template lists a subcutaneous injection, under the skin, while describing BAM15 as an oral compound elsewhere on the same page; one person described an intense reaction by both routes; and one site summarizes a podcast guest describing a skin application. There are no data on any of these routes in people. In the laboratory, researchers have packed BAM15 into microneedle patches and protein particles to get around its poor solubility and tested them in animals, but those are research formulations rather than products on sale. [54], [41], [57], [58], [59]

How should BAM15 be stored, and how long does it last?

There is no official product label, because no regulator has approved it, so the only storage figures come from research-chemical suppliers and dosing pages, and they do not agree.

A laboratory supplier's data sheet for the raw chemical gives the longest usable periods at the coldest temperatures: the powder keeps for years in a freezer and less in a fridge, a prepared solution keeps for months rather than years, and repeated freezing and thawing is to be avoided. One dosing page repeats freezer storage for powder, dry and away from light, while retail capsule pages say room temperature, sealed and out of sunlight, and a directory page simply defers to the supplier while noting that the product is not made or labelled as a human medicine. [60], [24], [52], [23], [20]

Two limits matter. None of these figures comes from published stability testing of a finished consumer product, so a capsule's real shelf life is unknown. And BAM15's poor solubility means a homemade preparation can separate, which no storage advice fixes. [2], [24]

What do we actually know about BAM15 in people?

Nothing directly. No published study has given BAM15 to a person, and no human trial has been registered. A September 2026 search of ClinicalTrials.gov for BAM15 and related terms found no BAM15 study; the single hit was a COVID-19 antibody trial whose drug is abbreviated "BAM". [3]

So the claim, heard in community education groups, that clinical trials of BAM15 are already under way is not supported by any registry record we found. [3]

Some studies have used human material in a laboratory: donated sperm, immune cells, lab-grown retinal tissue and liver enzymes. They show how BAM15 behaves with human cells in a dish, and measured nothing about benefit or safety in a living person. [61], [62], [63], [56]

Who did the research?

Much of the fat-loss work comes from a few connected laboratories in Virginia, Australia and Louisiana, several authors disclose a financial interest in companies developing mitochondrial uncouplers, and the original discovery is covered by a university patent. That does not make the findings wrong, but independent repetition matters, and independent groups have since used BAM15 mainly in other disease models. [2], [9], [64], [65]

Is anyone developing BAM15 as a medicine?

Not that we could find. The groups behind BAM15 have moved on to related compounds, including chemical derivatives and a liver-targeted uncoupler tested in mice. Whatever those show will describe them, not the BAM15 sold online. [66], [67]

What would a useful result even look like?

A single number on a scale is a weak guide. Waist measurement, body composition, energy through the day, sleep, resting heart rate and how warm you feel are separate outcomes, and a GLP-1 medicine, a diet change or new training can move all of them at once. The mouse studies measured fat and muscle separately from body weight for exactly this reason. [2], [9], [36]

How might BAM15 work?

Mitochondria make the body's energy currency, a molecule called ATP. They do it by pumping protons, positively charged particles, across an inner membrane, then letting them flow back through a tiny turbine that builds ATP. It works like a dam: water held behind it turns a turbine on the way down. [1]

BAM15 is a protonophore. It carries protons back across the membrane without passing through the turbine, like a leak in the dam. The mitochondria then burn more fat and sugar to keep making the same amount of ATP, and the extra energy is released as heat. That is what "uncoupling" means: fuel burning is partly uncoupled from energy production. [1], [68]

How is it different from DNP?

DNP and older laboratory uncouplers also leak protons across other cell membranes, which disturbs the whole cell and narrows the gap between a useful and a toxic amount. In the screen that discovered it, BAM15 did not discharge the outer plasma membrane of cultured cells, and it was less toxic to them than an equally potent older uncoupler. A later study found it could still disturb the plasma membrane of nerve cells from a mollusk, so "mitochondria only" is a laboratory finding rather than a rule. Part of the effect also runs through a protein in the mitochondrial membrane that normally swaps ATP for its spent form, and how much varies by tissue. [1], [68], [69], [70]

Does it raise body temperature?

Not in the mouse studies that measured it. Mice eating BAM15, or given it by injection, kept a normal body temperature, and in one cancer study it was slightly lower. Those mice were housed at about 22 °C (72 °F), and a mouse result cannot show what happens in a person. People who describe taking BAM15 report feeling hot and sweating more than any other effect, and nobody has measured a temperature in one of them, so for people the honest answer is that it is unknown. [2], [9], [71], [32], [37], [35]

Is BAM15 an AMPK activator?

In a sense. AMPK is the cell's fuel gauge: it switches on when energy runs low. By making mitochondria less efficient, BAM15 lowers the cell's energy charge, and AMPK responds. It activated AMPK strongly in rat blood-vessel cells and in mouse liver. The World Anti-Doping Agency lists BAM15 as an example of an AMPK activator for that reason, although its primary action is uncoupling. [72], [73], [8], [74]

What are the risks and unanswered questions?

Is BAM15 safe?

Nobody knows, because it has never been studied in a person. Everything known comes from short animal experiments, which found few obvious problems in mice, including normal results on the blood tests that were run, but also produced four warning signs. [3], [2], [71]

• Heart, in pigs. In an imaging study of four anesthetized minipigs, BAM15 infused straight into a heart artery caused severe heart dysfunction in one animal at the highest rate, and that infusion was stopped after 10 minutes. The route and the solvent may have contributed, but this is the only test in a larger animal. [10]
• Lethargy, in mice. At the top of the single-amount range, mice became briefly lethargic, and the researchers could not separate the drug from the thick paste used to deliver it. Testing stopped there because the compound would no longer dissolve. [2]
• Muscle loss in combination. In fatty-liver mice fed matched amounts of food, BAM15 given with a liver drug left them with 6.2% less lean mass than untreated mice. In a separate experiment where the mice ate freely, the combination group ate more, which is why the researchers matched the food. [13]
• Toxic to cells at higher levels. One research team writes that BAM15 toxicity "has been reported, especially in high doses", and free BAM15 was toxic to cultured immune cells in their experiments. [75]

What has not been done matters as much. We found no published standard safety testing: no long-term toxicity studies, no heart-rhythm tests, no tests for genetic damage or cancer, and no reproductive safety studies. The class carries a known danger, since DNP causes fatal overheating in people, and no study has shown where BAM15's limit lies in a human body. [11], [2]

What problems have people reported?

Public accounts describe feeling hot, heavy sweating including night sweats, tiredness or lethargy, diarrhea when taken without food, a faster resting heart rate, changed sleep and, in one case, an unusual body odor that stopped when the person stopped taking it. Most of those people were also taking other compounds. In community education groups, heat and sweating are the most consistent reports, one member described severe exhaustion after raising their amount quickly while adding another compound, and another said a wearable showed worse heart-rate readings. [35], [51], [37], [36], [42]

None of this establishes cause or frequency, and nobody reported a measured temperature or a blood test. The community section gives the details. [38]

Could product quality change the risk?

Yes. The World Anti-Doping Agency states that BAM15 "has been found in supplements", without naming the products or saying whether their labels listed it, and we found no published independent testing of the capsules on sale. Label problems are easy to find: blend capsules described in micrograms by one seller and milligrams by another, a retail page that describes its BAM15 as an enzyme, and blends that never state the amount at all. BAM15 also dissolves so poorly that homemade capsules may not hold even amounts. [74], [76], [30], [31], [55], [33], [2]

Is BAM15 legal? Is it FDA-approved?

Checked September 23, 2026. Rules differ by country and change quickly.

United States. BAM15 is not an approved drug: a search of the FDA's approved-drug database returned no match. It does not appear in the FDA's section 503A categories of bulk substances nominated for use by compounding pharmacies, nor on the FDA's list of new dietary ingredient notifications through July 2026. External searches of fda.gov found no warning naming BAM15, although the FDA's own site search could not be opened, so that is a no-hit result rather than a confirmed zero. The FDA's warnings about DNP apply to that older uncoupler. [5], [77], [78], [11]

Canada. Searches of Health Canada's drug product database, its licensed natural health products database and its ingredients database returned no BAM15 entry, and the recalls and advisories search returned nothing for it. [6], [79], [80]

Australia. No BAM15 entry was found in the searches performed. Keyword searches of the Australian Register of Therapeutic Goods returned only unrelated products whose names happen to contain similar letters, and BAM15 is not named in the June 2026 Poisons Standard text we checked. [7], [81]

A "research use only" label does not make a product legal to sell or safe to use for human consumption. [20]

Is BAM15 banned in sport? Does it show up on a drug test?

Yes, it is banned. The World Anti-Doping Agency names BAM15 on its 2026 list under S4.4.1, activators of AMPK, which are prohibited at all times, in and out of competition, and the 2027 list keeps it there from January 1, 2027. Both the agency and the United States Anti-Doping Agency warn that the substance has been found in supplements, so an athlete can take it without knowing. [8], [82], [74], [76]

No published study reports how long BAM15 stays detectable. A 2026 laboratory study of human liver enzymes proposed one of its breakdown products as a marker for anti-doping testing, which is a step toward a test rather than a detection window. [56]

Who should be especially cautious?

None of these groups has safety data, because no group does. That is a reason for caution, not proof of harm. [3]

• Anyone with heart disease or a fast or irregular heartbeat. The only test in a larger animal caused severe heart dysfunction, and some people report a faster resting heart rate. [10], [37]
• Anyone prone to overheating, in hot weather, during a fever or in hard exercise. Uncouplers release energy as heat, and overheating is the main danger of DNP. [1], [11]
• Pregnancy, trying to conceive and breastfeeding. No reproductive safety studies exist, and in a laboratory test BAM15 reduced the swimming ability of donated human sperm. [61]
• People taking medicines that lower blood sugar. BAM15 lowered blood sugar in diabetic mice, and it is often added to GLP-1 medicines. [39], [83]
• Anyone under 18, since no study includes young people, and competitive athletes, who are covered by the sport rules above. [3], [8]

Has BAM15 been tested alongside other medicines?

Not in people. Mouse studies have combined BAM15 with semaglutide and with a liver drug, but they cannot show how the combination behaves in a person, and there are no human interaction data of any kind. [83], [13] The only other relevant laboratory work incubated BAM15 with human liver enzymes to identify its breakdown products, which does not tell you how it behaves with another drug in a living body. [56]

The theoretical concerns are combinations that add heat or strain on the heart: another uncoupler, thyroid hormone, or stimulants, all of which appear in public stack reports. One dosing site calls combining two uncouplers the single most dangerous error in this category. The usual combinations, with SLU-PP-332 or a GLP-1 medicine, have not been studied in people either. Bring a complete list of everything you take to a pharmacist or doctor. [23], [51], [84]

What should be monitored while using BAM15?

There is no monitoring plan for BAM15, because there is no approved product, no label and no human study to base one on. What follows is what researchers measured in animals and what the sources themselves describe, so you can see how thin the ground is. Anything you are considering belongs in a conversation with a clinician. [3]

What the animal studies measured. The mouse studies tracked body weight and the split between fat and muscle, food intake, blood sugar handling and body temperature, and ran standard blood chemistry and blood-count panels, which were normal in those short studies. The minipig study measured heart function directly, which is how its harm signal was found. Nothing measured how any of this behaves in a person. [2], [9], [71], [10]

What the sources themselves watch. Several dosing pages pair their schedules with a thermometer, with attention to heart rate and sleep, and some mention liver blood tests before and during a course. These are precautions those pages invented, not thresholds any study has tested. [24], [18], [23] Educators in community education groups describe watching temperature in the same way.

In the tracking categories Doserly uses, the measures that come up most often in this evidence are temperature regulation, heart rate and palpitations, energy levels, sleep quality, digestive comfort, weight management and fat loss, and overall side-effect burden. Blood tests, such as liver enzymes and blood sugar, are a separate matter for a clinician to order and interpret. [2], [35], [37]

The honest summary is that no measurement has been shown to catch a problem early in a person, because the problems in people have never been described. [3]

What do people in public communities report?

Public discussions include people who felt warmer and more energetic, people who noticed nothing, and people who stopped because of tiredness. Almost everyone describing a result was also dieting, training harder or taking something else, most often SLU-PP-332 or a GLP-1 medicine, and nobody published a measured temperature, a body-composition scan or a blood test. One caution before the themes: a large share of these posts come from online groups run alongside vendor or ranking websites, and in one of them a single author wrote 17 of the 42 archived BAM15 posts, counted once here. [32], [35], [36], [85], [38], [18]

What do the positive reports look like?

The most common is feeling warmer. One person taking about 100 mg a day on its own for a few weeks felt warmer than usual and less hungry, and said the warmth was not uncomfortable. Another, using a capsule that combined BAM15 with a different compound, reported losing several pounds by the third week and feeling warmer, then paused BAM15 because of lethargy. Fat-loss reports are usually modest or tangled with other changes: someone whose body-fat analyzer estimated about 8 pounds of fat loss over a month was also taking retatrutide and dieting, and agreed that either could explain it. [37], [35], [36]

Does everyone notice a difference?

No. One person took BAM15 for two months and noticed "absolutely no effect at all", suspecting a fake product; another felt nothing at a low amount; and someone who took a large amount three times a day for three weeks during a calorie deficit judged the result "maybe slightly better" than dieting alone and not worth the cost. Posts from one active group put it more bluntly: no fat loss after six weeks, "useless for fat loss" after three months, and in that group's most positive post, about 1% of body fat over six weeks, which the author still called mediocre. [86], [87], [40], [85], [88], [38]

Does a higher amount work better?

Not reliably. One person who raised their amount fourfold over a week said it was hardly doing anything however much they took. Another said they could not tolerate the amount they had planned at all and described an intense reaction. The largest figures in public posts come with no measured outcome, including one blog log that records the exposure and states plainly that no result has been recorded. [89], [41], [50]

What about unwanted effects?

Tiredness is the surprise for many people expecting more energy. One person felt "so so tired" after four days; another linked lethargy to BAM15 and stopped it. Others describe night sweats even with the air conditioning on, diarrhea without food, a resting heart rate they estimated at about 5 beats per minute higher, and more hunger with disturbed sleep. [35], [51], [37], [42]

In community education groups, members describe the same heat and sweating, one case of severe exhaustion after a rapid increase while adding another compound, and one person whose wearable showed worse heart-rate readings. Educators there treat a small temperature rise as a reason to cut back, which is a rule of thumb rather than a tested threshold.

How can you judge a fat-loss story?

Useful questions to ask: What else changed, including diet, training or a GLP-1 medicine? Was fat measured, or just felt? Over how long? Is there a follow-up weeks later, or does the story stop at the exciting part? And who wrote it, and do they sell anything? These selected discussions show what people try and what they notice. They are not a survey of everyone who has used BAM15, a response rate, or a substitute for controlled trials. [36], [38], [50], [3]

How does BAM15 compare with the compounds it is sold beside?

BAM15 is usually bought alongside other metabolic compounds, so it helps to see where each one actually stands. The table compares them on what they are, how they are taken, how strong the human evidence is and whether any regulator has approved them.

Two differences matter most. First, evidence: semaglutide has been tested in thousands of people, while BAM15, SLU-PP-332 and 5-Amino-1MQ have not been given to anyone in a published study. Second, mechanism: GLP-1 medicines mainly reduce how much you eat, while BAM15 was designed to make energy production less efficient, and in mice its effect appeared without any drop in food intake. That difference is the reason people combine them, and it is also why a combination has never been tested for safety in a person. [94], [2], [83]

Nothing here says one compound is better than another. It says what has been tested, and in whom.

Common questions about BAM15

Is BAM15 a peptide?

No. It is a small molecule with no amino-acid chain, weighing about 340 g/mol, far less than a typical peptide. It is sold by peptide shops, which is why the label sticks, and some pages even describe injecting it although it was designed to be swallowed. A page that calls it a peptide has not checked the basics. [4], [54] See what it is.

Is BAM15 just a safer DNP?

Not proven. Both are uncouplers, and in mice BAM15 did not raise body temperature even far above the amounts where DNP caused problems in the same tests. But it has never been given to a person, so its margin in a human body is unknown, and people who take it describe heat and sweating. [2], [11], [35] See the DNP comparison.

How long does BAM15 take to work?

There is no established timeline, because no study has measured one in a person. Public reports range from feeling something on the first day to modest changes after several weeks, and nothing at all after two months. In mice, fat loss built up over three to five weeks, which does not translate into human time. [2], [9], [95], [86] See what people reported.

Does BAM15 work without a calorie deficit?

In some mice, yes: obese mice eating as much as they wanted still lost fat. But in diabetic mice at the same food level, and in fatty-liver mice, it made little or no difference. In people, the reports that describe a result almost always involve dieting, training or another compound. [2], [39], [13], [40] See the mouse results.

Can you take BAM15 with a GLP-1 medicine like semaglutide, tirzepatide or retatrutide?

Many people do, and the combination has never been studied in a person. In obese mice, a low level of BAM15 with a low dose of semaglutide reduced body fat and liver fat when neither did alone. The combination also improved how the mice handled a sugar load, although fasting blood sugar did not change significantly. Reports from people taking both cannot show what BAM15 added, and a combination untested in people is a reason to raise it with a clinician rather than assume it is safe. [83], [36] Read the Doserly guides to semaglutide, tirzepatide and retatrutide.

Should BAM15 be stacked with SLU-PP-332?

It is the most common pairing, and it is untested. Blend labels disagree about the BAM15 content by a factor of a thousand, so buyers often cannot tell what they have, and neither compound has human data. [30], [31], [32], [34] Read the Doserly guides to SLU-PP-332 and the SLU-PP-332 and BAM15 blend.

Are there clinical trials of BAM15?

No. We found no registered or published human trial as of September 2026. The ClinicalTrials.gov result that appears for "BAM" is a COVID-19 antibody study, and the research groups behind BAM15 have moved on to related molecules tested in animals. [3], [67] See what we know in people.

Is it legal to buy BAM15, and does it show up on a drug test?

We found no approval for it anywhere we checked: no match in the FDA's approved-drug database, and no BAM15 entry in the Health Canada and Australian searches performed. Those searches cannot settle whether a particular sale or purchase is lawful where you live, and a "research use only" label does not make it legal. For athletes the answer is simpler: it is banned at all times under the 2026 and 2027 prohibited lists, and a laboratory study has already proposed a marker for testing. [5], [6], [7], [8], [82], [56] See the dated legal-status summary.

Glossary

Plain explanations of the route, dosing and research terms used in this guide. Underlined terms in the text link here.

Adverse event

A harmful or unwanted medical event reported after someone used a treatment. A report alone does not prove the treatment caused it.

AMPK

AMP-activated protein kinase, the cell's fuel gauge. It switches on when energy runs low and tells the cell to burn more fuel. Anti-doping rules ban drugs that activate it.

Animal study

Research in animals such as mice, rats or pigs. It shows what a substance does in a living body, but results in people can differ.

Bioavailability

How much of an amount taken reaches the bloodstream in a usable form. For BAM15 swallowed by mice it was 67%, and it has never been measured in people.

Blend

A product that combines BAM15 with another compound, such as SLU-PP-332. The blend's total weight is not its BAM15 content.

Cell study (in vitro)

Research on cells grown in a dish. It gives early clues about biology, but it is far from proof of benefit in people.

Compounding

When a pharmacy prepares a customized medicine from individual ingredients. In the US, federal lists control which bulk ingredients pharmacies may use.

Controlled trial

A study that compares people who receive a treatment with a similar group who do not, often receiving a placebo instead. None has been done for BAM15.

Course and cycle

A course is a period of repeated use, such as eight weeks. A cycle is a course plus a planned break before any further use.

Daily total

All the amounts taken in one day, added together. It can differ from the strength printed on one capsule, because a label describes a single capsule, not a day.

DNP (2,4-dinitrophenol)

An older mitochondrial uncoupler once used for weight loss and banned for human use by the FDA in 1938. It can cause dangerously high body temperature and death.

DOI

Digital object identifier: the permanent reference code for a published paper. A wrong DOI on a page means its citation does not lead to the study it claims.

Dose (amount each time)

The amount taken on one occasion. It is not the same as the daily total, and for BAM15 no dose has been established in people.

GLP-1 medicine

Short for glucagon-like peptide-1 medicine: a class of weight-loss and diabetes drugs, such as semaglutide and tirzepatide, that mainly work by reducing appetite and slowing digestion. Retatrutide is an investigational drug in a related class.

Half-life

The time it takes for the measured level of a substance in the blood to fall by half. It is not the same as how long an effect lasts.

Human equivalent dose

A number calculated from an animal amount using a body-surface formula. Regulators use it as one step toward a cautious first amount in a supervised trial; it is not a tested human dose.

Intraperitoneal

Injected into the abdominal cavity, a common route in animal studies but not one people use.

Investigational

Still being studied and not approved by a regulator, such as the FDA, to treat any condition.

Lean mass

Everything in the body except fat, mostly muscle, organs, bone and water. Weight-loss studies measure it separately to see whether the weight lost was fat or muscle.

mcg and mg

Micrograms and milligrams. 1 mg equals 1,000 mcg, so a figure written in the wrong unit is off by a thousand times. BAM15 figures are usually in mg, but some blend labels use mcg.

Mitochondria

Tiny structures inside cells that turn food into usable energy (ATP). They are often called the cell's power plants.

Oral

Taken by mouth, as a capsule, tablet or liquid.

Peptide

A short chain of amino acids. BAM15 is not a peptide, although it is usually sold alongside them.

Pharmacokinetics

How the body absorbs, moves, breaks down and removes a substance. No such data exist for BAM15 in people.

Placebo

A dummy treatment with no active ingredient, used as a comparison in studies.

Plasma membrane

The outer skin of a cell, which separates it from its surroundings. It is different from the membranes inside mitochondria, and older uncouplers disturb it.

Preclinical research

Studies done before research in people: cell studies and animal studies.

Preprint

A research paper shared publicly before independent experts have reviewed it for a journal.

Protonophore

A chemical that carries protons across a membrane. In mitochondria, this lets energy escape as heat instead of being stored as ATP.

Registered study plan

A trial described in a public registry such as ClinicalTrials.gov before or while it runs. Registration is not a result, and none exists for BAM15.

Research use only

A label on products sold for laboratory research. It does not mean a product is approved, tested for human use or legal to sell as a medicine.

Small molecule

A compact chemical compound, like most tablet medicines, as opposed to a peptide or protein made of linked amino acids.

Subcutaneous (SC)

Injected into the fatty layer just under the skin. A few BAM15 animal experiments used it; products sold for people are almost always swallowed.

Titration

Adjusting an amount in steps, usually starting lower and increasing. No stepped schedule for BAM15 has been tested in people.

Mitochondrial uncoupler

A substance that lets mitochondria burn fuel without making as much ATP, so more energy is released as heat. BAM15 and DNP are both uncouplers.

WADA

The World Anti-Doping Agency, which publishes the list of substances banned in sport.

% w/w in food

Percent of the food by weight. BAM15 at 0.1% w/w means 1 gram of BAM15 in every kilogram of mouse food. It is a way of dosing animals, not a human amount.

Explore more of the research

Go deeper into the experiments behind the claims.

Across this guide, the citations include 49 original scientific papers and preprints on BAM15 and its close chemical relatives, all preclinical, meaning in cells, tissues or animals; the comparison section adds three papers on other compounds. The library below groups 46 of the BAM15 papers by question, and the other three are discussed in the main text. Paper counts are not counts of independent research teams, because several share authors. Registry searches, reviews, websites and personal accounts are counted separately.

In the details below, % w/w means percent of the food by weight, intraperitoneal means into the abdominal cavity and subcutaneous means into the fatty layer beneath the skin.

How this guide was researched

This guide is built from a thorough review of the sources cited throughout it: published scientific studies and preprints, trial-registry searches, regulatory documents, chemical databases and published protocol descriptions. We also reviewed public online forums and community education groups where people describe their own experiences with BAM15.

The guide cites 112 sources, including 52 original scientific papers and preprints. Each type of source answers a different question. Studies show what researchers measured. Protocol descriptions show what amounts are being promoted, not what is safe. Personal accounts show what individual people experienced. Every numbered citation links to its entry below, labeled by source type.

How this guide was made

Research and drafting were AI-assisted. Cited sources were checked against their originals, and each source entry notes when only an abstract, a publisher record or a snippet was available. The guide was reviewed and edited by Doserly before publication. It has not had an independent clinical review, and Doserly does not currently have medical reviewers. Doserly makes a medication and health-tracking app and runs Doserly Academy, both of which are promoted in this guide. Read our editorial policy for how guides are researched, updated and corrected.

This guide is for educational purposes. It summarizes what the reviewed sources report so the research is easier to understand; it is not medical advice. For a deeper dive, or to check any point for yourself, go straight to the cited sources.

Explore the sources